BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26068129)

  • 1. Suicidal ideation modulates the reduction in serotonin transporter availability in male military conscripts with major depression: A 4-[18F]-ADAM PET study.
    Yeh YW; Ho PS; Chen CY; Kuo SC; Liang CS; Yen CH; Huang CC; Shiue CY; Huang WS; Ma KH; Lu RB; Huang SY
    World J Biol Psychiatry; 2015 Oct; 16(7):502-12. PubMed ID: 26068129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incongruent reduction of serotonin transporter associated with suicide attempts in patients with major depressive disorder: a positron emission tomography study with 4-[18F]-ADAM.
    Yeh YW; Ho PS; Chen CY; Kuo SC; Liang CS; Ma KH; Shiue CY; Huang WS; Cheng CY; Wang TY; Lu RB; Huang SY
    Int J Neuropsychopharmacol; 2014 Oct; 18(3):. PubMed ID: 25522405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disproportionate Reduction of Serotonin Transporter May Predict the Response and Adherence to Antidepressants in Patients with Major Depressive Disorder: A Positron Emission Tomography Study with 4-[18F]-ADAM.
    Yeh YW; Ho PS; Kuo SC; Chen CY; Liang CS; Yen CH; Huang CC; Ma KH; Shiue CY; Huang WS; Shyu JF; Wan FJ; Lu RB; Huang SY
    Int J Neuropsychopharmacol; 2015 Jan; 18(7):pyu120. PubMed ID: 25568284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N,N-dimethyl-2-(2-amino-4-(18)F-fluorophenylthio)-benzylamine (4-(18)F-ADAM): an improved PET radioligand for serotonin transporters.
    Shiue GG; Choi SR; Fang P; Hou C; Acton PD; Cardi C; Saffer JR; Greenberg JH; Karp JS; Kung HF; Shiue CY
    J Nucl Med; 2003 Dec; 44(12):1890-7. PubMed ID: 14660713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron Emission Tomographic Imaging of the Serotonergic System and Prediction of Risk and Lethality of Future Suicidal Behavior.
    Oquendo MA; Galfalvy H; Sullivan GM; Miller JM; Milak MM; Sublette ME; Cisneros-Trujillo S; Burke AK; Parsey RV; Mann JJ
    JAMA Psychiatry; 2016 Oct; 73(10):1048-1055. PubMed ID: 27463606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of N,N-dimethyl-2-(2-amino-5-[18F]fluorophenylthio)benzylamine (5-[18F]-ADAM) as a serotonin transporter imaging agent.
    Fang P; Shiue GG; Shimazu T; Greenberg JH; Shiue CY
    Appl Radiat Isot; 2004 Dec; 61(6):1247-54. PubMed ID: 15388117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution volume ratio of serotonin and dopamine transporters in euthymic patients with a history of major depression - a dual-isotope SPECT study.
    Hsieh PC; Lee IH; Yeh TL; Chen KC; Huang HC; Chen PS; Yang YK; Yao WJ; Lu RB; Chiu NT
    Psychiatry Res; 2010 Dec; 184(3):157-61. PubMed ID: 21030217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET imaging of the brain serotonin transporters (SERT) with N,N-dimethyl-2-(2-amino-4-[18F]fluorophenylthio)benzylamine (4-[18F]-ADAM) in humans: a preliminary study.
    Huang WS; Huang SY; Ho PS; Ma KH; Huang YY; Yeh CB; Liu RS; Cheng CY; Shiue CY
    Eur J Nucl Med Mol Imaging; 2013 Jan; 40(1):115-24. PubMed ID: 23053324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of 4-[18F]-ADAM as a SERT imaging agent using micro-PET and autoradiography.
    Ma KH; Huang WS; Kuo YY; Peng CJ; Liou NH; Liu RS; Hwang JJ; Liu JC; Chen HJ; Shiue CY
    Neuroimage; 2009 Apr; 45(3):687-93. PubMed ID: 19211037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating the effects of noise-induced hearing loss on serotonin transporters in rat brain using 4-[18F]-ADAM/small animal PET.
    Kang HH; Wang CH; Chen HC; Li IH; Cheng CY; Liu RS; Huang WS; Shiue CY; Ma KH
    Neuroimage; 2013 Jul; 75():262-269. PubMed ID: 22766166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study.
    Newberg AB; Amsterdam JD; Wintering N; Ploessl K; Swanson RL; Shults J; Alavi A
    J Nucl Med; 2005 Jun; 46(6):973-7. PubMed ID: 15937308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased brainstem and putamen SERT binding potential in depressed suicide attempters using [11C]-zient PET imaging.
    Nye JA; Purselle D; Plisson C; Voll RJ; Stehouwer JS; Votaw JR; Kilts CD; Goodman MM; Nemeroff CB
    Depress Anxiety; 2013 Oct; 30(10):902-7. PubMed ID: 23526784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of 4-[18F]-ADAM as an imaging agent for SERT in non-human primate brain using PET: a dynamic study.
    Chen YA; Huang WS; Lin YS; Cheng CY; Liu RS; Wang SJ; Li IH; Huang SY; Shiue CY; Chen CY; Ma KH
    Nucl Med Biol; 2012 Feb; 39(2):279-85. PubMed ID: 22136885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of two fluoro-analogues of N,N-dimethyl-2-(2'-amino-4'-hydroxymethyl-phenylthio)benzylamine as serotonin transporter imaging agents using microPET.
    Jarkas N; Voll RJ; Williams L; Goodman MM
    Nucl Med Biol; 2010 Jul; 37(5):593-603. PubMed ID: 20610164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association study of serotonin transporter availability and SLC6A4 gene polymorphisms in patients with major depression.
    Ho PS; Ho KK; Huang WS; Yen CH; Shih MC; Shen LH; Ma KH; Huang SY
    Psychiatry Res; 2013 Jun; 212(3):216-22. PubMed ID: 23149035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of brain SERT occupancy by resveratrol against MDMA-induced neurobiological and behavioral changes in rats: A 4-[¹⁸F]-ADAM/small-animal PET study.
    Shih JH; Ma KH; Chen CF; Cheng CY; Pao LH; Weng SJ; Huang YS; Shiue CY; Yeh MK; Li IH
    Eur Neuropsychopharmacol; 2016 Jan; 26(1):92-104. PubMed ID: 26612383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuated serotonin transporter association between dorsal raphe and ventral striatum in major depression.
    Hahn A; Haeusler D; Kraus C; Höflich AS; Kranz GS; Baldinger P; Savli M; Mitterhauser M; Wadsak W; Karanikas G; Kasper S; Lanzenberger R
    Hum Brain Mapp; 2014 Aug; 35(8):3857-66. PubMed ID: 24443158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of SSRI treatment response in major depression based on serotonin transporter interplay between median raphe nucleus and projection areas.
    Lanzenberger R; Kranz GS; Haeusler D; Akimova E; Savli M; Hahn A; Mitterhauser M; Spindelegger C; Philippe C; Fink M; Wadsak W; Karanikas G; Kasper S
    Neuroimage; 2012 Nov; 63(2):874-81. PubMed ID: 22828162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin transporter binding with [123I]beta-CIT SPECT in major depressive disorder versus controls: effect of season and gender.
    Ruhé HG; Booij J; Reitsma JB; Schene AH
    Eur J Nucl Med Mol Imaging; 2009 May; 36(5):841-9. PubMed ID: 19183998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower serotonin transporter binding potential in the human brain during major depressive episodes.
    Parsey RV; Hastings RS; Oquendo MA; Huang YY; Simpson N; Arcement J; Huang Y; Ogden RT; Van Heertum RL; Arango V; Mann JJ
    Am J Psychiatry; 2006 Jan; 163(1):52-8. PubMed ID: 16390889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.